Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma
Clinical trial NCT02934204 · UNKNOWN
Trial details
- NCT number
- NCT02934204
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2019-02-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.